|
US - King Pharmaceuticals Inc acquired the AVINZA product line of Ligand Pharmaceuticals Inc, a manufacturer of pharmaceuticals, for $### mil. The consideration consisted of $### mil and the assumption of $## mil in liabilities. The transaction had been subject to…
|
| Credit & Investment Research |
|
|